在帕金森病中早期检测视网膜变化的潜在生物标志物的实施:关于BDNF作用的初步研究
Mariaelena Malvasi1, Esterina Pascale2, Nicoletta Locuratolo3,4
1Department of Sense Organs, Sapienza University of Rome, Roma, Italy.
European journal of ophthalmology
|April 17, 2025
概括
帕金森病 (PD) 与斑点视网膜厚度的变化有关,可通过光学连贯断层扫描 (OCT) 检测到. 这种非侵入性成像可以作为PD检测的早期生物标志物.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 的视觉功能障碍表明视网膜多巴胺基层退化.
- 光学连贯断层扫描 (OCT) 是一种非侵入性方法,用于体内视网膜成像.
- 需要对BDNF基因的Val66Met多态性在PD相关的视网膜变化中的作用进行研究.
研究的目的:
- 为了研究PD患者的斑点视网膜厚度,与使用OCT的健康对照进行比较.
- 探索BDNF Val66Met多态和PD视网膜退化之间的关联.
- 为了将视网膜厚度与PD的临床特征相关联,包括发病时的年龄.
主要方法:
- 一项病例对照研究,涉及26名异常病态PD患者和78名健康对照.
- 对208只眼睛进行了黄斑区域的体积计OCT扫描.
- 斑点厚度被测量在各个部门和总的平均值; BDNF Val66Met多态是基因型.
主要成果:
- 在特定部门 (上OS2,下OS2) 和PD患者和对照组之间的总体积中观察到斑点厚度的显著差异.
- 发现视网膜厚度与在部和下部部门发病时的年龄之间存在反向相关性.
- 瓦尔/梅特异性BDNF多态存在于PD患者的30.7%.
结论:
- 内视网膜层的稀薄已被证实与帕金森病有关.
- OCT是一种可行的,非侵入性的工具,用于评估视网膜层,可能作为早期PD生物标志物.
- 需要进一步的研究来阐明BDNF多态性在PD相关的视网膜退化中的作用.
相关概念视频
01:37Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
01:24Parkinson's Disease: Treatment
152
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
152
01:15Parkinson's Disease: Overview
311
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
311